866775-17-9

Basic information

• Product Name: 3-Amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester
• Synonyms: 3-Amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester;2-Pyridinecarboxylic acid, 3-amino-5-(trifluoromethyl)-, methyl ester
• CAS NO: 866775-17-9
• Molecular Formula: C₈H₇F₃N₂O₂
• Molecular Weight: 220.1485896
• Mol File: 866775-17-9.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester(866775-17-9)
• EPA Substance Registry System: 3-Amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester(866775-17-9)

Safety Data

• Hazardous Substances Data: 866775-17-9(Hazardous Substances Data)

Usage

General Description

3-Amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester is a chemical compound with the molecular formula C8H7F3N2O2. It is an ester derivative of the amino acid pyridine-2-carboxylic acid, with a methyl group attached to the carboxyl group. The presence of a trifluoromethyl group and an amino group in the pyridine ring makes this compound useful in pharmaceutical and agrochemical applications. It is also used as a building block for the synthesis of various biologically active compounds. 3-Amino-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester is a white solid with a molecular weight of 224.15 g/mol and is commonly used as a reagent in organic synthesis.

Upstream product

• 655235-65-7 methyl 3-chloro-5-(trifluoromethyl)pyridine-2-carboxylate 
• 72587-15-6 2-chloro-3-nitro-5-(trifluoromethyl)pyridine 
• 67-56-1 methanol 
• 866775-16-8 3-nitro-5-trifluoromethyl-pyridine-2-carbonitrile 
• 1211515-30-8 3-amino-5-(trifluoromethyl)picolinonitrile 
• 1214336-90-9 3-amino-6-(2,6-difluorophenyl)-5-trifluoromethyl-2-pyridinecarboxylicacid 
• 33252-64-1 3-nitro-5-trifluoromethylpyridin-2-ol 

Downstream Products

• 866775-18-0 3-amino-6-bromo-5-trifluoromethyl-pyridine-2-carboxylic acid methyl ester 
• 1334546-83-6 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 
• 1214370-77-0 3-amino-5-trifluoromethylpyridine-2-carboxylic acid 
• 1334547-21-5 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 
• 1334547-23-7 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid methyl ester 
• 1334546-80-3 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid ((S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl)amide 
• 1427262-61-0 3-amino-6-bromo-N'-(2-phenylacetyl)-5-(trifluoromethyl)picolinohydrazide 
• 1427262-60-9 2-(5-benzyl-1,3,4-oxadiazol-2-yl)-6-bromo-5-(trifluoromethyl)pyridin-3-amine 
• 1427262-81-4 (R)-benzyl 2-(2-(3-amino-6-bromo-5-(trifluoromethyl)picolinoyl)hydrazinyl)-2-oxo-1-phenylethylcarbamate 
• 1427262-83-6 (R)-benzyl (5-(3-amino-6-bromo-5-(trifluoromethyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)(phenyl)methylcarbamate 
• 1427262-80-3 (R)-2-(5-(amino(phenyl)methyl)-1,3,4-oxadiazol-2-yl)-6-bromo-5-(trifluoromethyl)pyridin-3-amine 
• 1427400-25-6 3-amino-6-(4-fluorophenyl)-N-(1H-pyrazol-3-yl)-5-(trifluoromethyl)picolinamide 
• 1427400-35-8 methyl 3-amino-6-(4-fluorophenyl)-5-(trifluoromethyl)picolinate 

Relevant articles and documents

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.

Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.

PYRIDINE/PYRAZINE AMIDE DERIVATIVES

The present invention provides pyridine/pyrazine amide derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthm